Xiaofeng Ding | Biochemistry | Best Researcher Award

Posted on by sciencefather

Prof. Xiaofeng Ding | Biochemistry | Best Researcher Award

Hunan Normal University, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Prof. Xiaofeng Ding (丁小凤) was born in Hunan Province, China, on October 21, 1979. Her academic journey began with a Bachelor’s degree in Biology from the College of Life Sciences, Hunan Normal University in 2002. Driven by a passion for molecular sciences, she pursued a Master’s degree in Biochemistry and Molecular Biology at the same institution, completing it in 2005 under the guidance of Dr. Jian Zhang. She further deepened her research expertise by earning a Ph.D. in Genetics from Nanjing University’s Model Animal Research Center in 2008, under the mentorship of renowned scientist Dr. Xiang Gao. This rigorous academic foundation provided her with the knowledge and research discipline essential for a career in biomedical sciences.

🧑‍🔬 Professional Endeavors

Prof. Ding’s professional journey showcases an impressive trajectory of advancement in academia and international research. Starting as a Lecturer in Biochemistry and Molecular Biology at Hunan Normal University in 2008, she was quickly promoted to Associate Professor by 2010 and became a full Professor by December 2017. Her international exposure includes a significant postdoctoral research position (2014–2016) at the University of New Mexico, USA, under Prof. Meilian Liu. Since January 2025, she has expanded her global footprint as a Research Scientist II at the National Primate Research Center, Tulane University, collaborating with Dr. Xuebin Qin on translational biomedical research.

🔬 Contributions and Research Focus

Prof. Ding’s research is anchored in biochemistry, molecular biology, and genetics with a strong focus on disease mechanisms, protein chemistry, and developmental biology. She has contributed extensively to understanding cellular pathways involved in metabolic disorders and cancer. Her work on tumor metabolism and protein interaction networks has potential implications for innovative treatments of chronic diseases and cancers. By integrating biochemical techniques with genetic tools, she bridges molecular mechanisms with therapeutic outcomes, especially in relation to human disease models.

🌟 Impact and Influence

Prof. Ding’s influence extends beyond laboratory research. As a dedicated mentor, she has nurtured young talents and inspired many students and researchers in China and abroad. Her leadership roles in scientific societies—including her position as director of the Hunan Society of Biochemistry and Molecular Biology and her membership in the Tumor Metabolism Professional Committee—highlight her commitment to shaping the future of biomedical science in China. Her work contributes to the broader understanding of disease biology and encourages interdisciplinary collaborations in health sciences.

📊 Academic Citations and Recognition

While the document does not specify citation metrics, Prof. Ding’s extensive publication record and international collaborations strongly suggest a growing academic footprint in biomedical research. Her association with global research hubs like the University of New Mexico and Tulane University adds visibility to her scholarly output. Her work in tumor metabolism and protein chemistry is increasingly cited by researchers in cancer biology, metabolic regulation, and therapeutic development.

🛠️ Technical and Research Skills

Prof. Ding is highly proficient in a wide array of laboratory and research techniques. Her technical strengths include molecular cloning, protein expression analysis, biochemical assays, and in vivo disease modeling. She is also skilled in advanced tools for genetic manipulation and cell biology, which she applies to elucidate complex signaling pathways. Her experience in both Chinese and American research laboratories equips her with a unique dual perspective in managing research infrastructure and interdisciplinary projects.

👩‍🏫 Teaching and Mentorship

As a professor and former associate professor at Hunan Normal University, Prof. Ding has played a central role in curriculum development and student training. She has guided undergraduate, postgraduate, and doctoral students through laboratory-based projects and theoretical studies in molecular biology. Her mentorship has contributed to the development of future researchers in life sciences and medical biotechnology.

🌱 Legacy and Future Contributions

Prof. Ding’s academic career reflects a legacy of commitment to research excellence and scientific leadership. Her long-term vision includes conducting groundbreaking research in disease biology and expanding collaborative networks across countries and disciplines. As a Research Scientist II at Tulane University and a leader in several biochemical societies, she is poised to make significant contributions to global health challenges through innovation and knowledge sharing. Her goal is to continue exploring disease mechanisms at the molecular level and translate discoveries into clinical strategies for cancer and metabolic disorders.

📖Notable Publications

AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damage
Authors: G. Huang, M. Ouyang, K. Xiao, S. Xiang, X. Ding
Journal: Life Sciences
Year: 2024

A Lipid-Sensitive Spider Peptide Toxin Exhibits Selective Anti-Leukemia Efficacy through Multimodal Mechanisms
Authors: P. Zhang, W. Luo, Z. Zhang, Y. Zeng, Z. Liu
Journal: Advanced Science
Year: 2024

Eosinophil-Associated Genes are Potential Biomarkers for Hepatocellular Carcinoma Prognosis
Authors: Q. Wang, Z. Zhang, H. Zhou, L. Li, X. Ding
Journal: Journal of Cancer
Year: 2024

Depletion of JunB increases adipocyte thermogenic capacity and ameliorates diet-induced insulin resistance
Authors: X. Zhang, X. Ding, C. Wang, Q.A. Wang, M. Liu
Journal: Nature Metabolism
Year: 2024

Wilfried Schwab | Biochemistry | Best Researcher Award 

Posted on by sciencefather

Dr. Wilfried Schwab | Biochemistry | Best Researcher Award 

Technische Universität München , Germany

Profiles

Early Academic Pursuits

Prof. Dr. Wilfried Schwab’s academic journey began with the Abitur at Balthasar-Neumann-Gymnasium in Marktheidenfeld in 1980. He pursued a degree in Food Chemistry at the University of Würzburg (1981–1985), completing his 1st State Examination. Driven by a passion for natural product chemistry, he began his Ph.D. under Prof. Dr. Peter Schreier, completing it in 1989. His early research focused on the chemistry of natural flavors, a theme that would define much of his career. He then underwent professional training for the 2nd State Examination in Erlangen (1990–1991). His academic foundation was further strengthened with a Habilitation (1999), granting him venia legendi in Food Chemistry.

Professional Endeavors

Prof. Schwab’s postdoctoral career launched in the USA (1989–1990) at Washington State University with Prof. Rodney Croteau, a leading figure in plant biochemistry. He held several short-term research positions across Europe and the U.S., building a network of international collaborations. From 1994 to 2003, he led an independent research group at the University of Würzburg, where he developed his expertise in plant secondary metabolism. In 2003, he became a C3 professor at the Technical University of Munich (TUM), leading the Chair of Biomolecular Food Technology, which was renamed Biotechnology of Natural Products in 2010. His leadership extended to serving as acting head of multiple departments at TUM and a Chair Professorship at Anhui Agricultural University in China (since 2018), highlighting his global academic reach.

Research Focus and Scientific Contributions

Prof. Schwab’s research is anchored in the biochemistry of plant-derived natural products, particularly focusing on glycosyltransferases, terpenoids, apocarotenoids, and flavor compounds. He has significantly advanced the understanding of enzyme structure–function relationships and metabolic pathways in fruits like strawberry and grapevine. His work bridges basic and applied science, often connecting plant metabolic processes with practical applications in food chemistry, fragrance, and biotechnology.

Impact and Influence

With a rich publication history in top-tier journals such as Nature Communications, New Phytologist, Plant Physiology, and Nature Genetics, Prof. Schwab has made substantial contributions to the scientific community. His involvement in the woodland strawberry genome project underscores his role in major collaborative efforts. Additionally, he holds several patents, including methods for identifying glycosyltransferase substrates and aroma precursors, demonstrating his impact beyond academia and into industrial applications.

Academic Citations and Recognition

Prof. Schwab’s publications have been widely cited, with key studies serving as references for both academic and applied research in plant biochemistry. He received the Unterfränkische Gedenkjahresstiftung für Wissenschaft award for his Ph.D. thesis and the Josef-Schormüller Award in 1999, recognizing his exceptional contributions to food chemistry. He also serves on the editorial board of Horticultural Research, reflecting peer recognition of his expertise.

Technical Skills

Prof. Schwab possesses deep technical expertise in enzymology, plant metabolomics, analytical chemistry (GC-MS, LC-MS), and molecular biology. His ability to translate complex biochemical pathways into functional insights about plant defense and aroma biosynthesis has made him a leader in the field. He has also demonstrated proficiency in industrial research, particularly during his time with Hoechst AG and AgrEvo (1991–1994), working on agricultural metabolism.

Teaching and Academic Leadership

Throughout his academic journey, Prof. Schwab has mentored numerous students and researchers. His leadership roles at TUM—including acting head of departments in Biofunctionality of Food and Fruit Science—highlight his commitment to nurturing future scientists. His teaching integrates foundational knowledge with state-of-the-art discoveries in biotechnology and natural products.

Legacy and Future Contributions

Prof. Schwab’s legacy is defined by his interdisciplinary approach, combining food chemistry, plant biology, and biotechnology to unravel nature’s complexity. As he continues his work in Germany and China, his research will likely influence sustainable agriculture, food innovation, and natural product development for years to come. His role in shaping modern food biochemistry ensures a lasting impact on both scientific discovery and industrial practice.

📖Notable Publications

β-Carotene alleviates substrate inhibition caused by asymmetric cooperativity

  • Authors: Jieren Liao, Umar F. Shahul Hameed, Timothy D. Hoffmann, Stefan T. Arold, Wilfried G. Schwab

  • Journal: Nature Communications

  • Year: 2025

Squalene acts as a feedback signaling molecule in facilitating bidirectional communication between tea plants

  • Authors: Jieyang Jin, Mingyue Zhao, Keke Yu, Wilfried G. Schwab, Chuankui Song

  • Journal: Science Advances

  • Year: 2025

Evolution and functional divergence of glycosyltransferase genes shaped the quality and cold tolerance of tea plants

  • Authors: Jingming Wang, Yutong Hu, Danyang Guo, Enhua Xia, Chuankui Song

  • Journal: Plant Cell

  • Year: 2025

Kinetics of Secoisolariciresinol Glucosyltransferase LuUGT74S1 and Its Mutants

  • Authors: Sadiq S. Mareai, Lukas Böhm, Thomas Hoffmann, Wilfried G. Schwab

  • Journal: Journal of Agricultural and Food Chemistry

  • Year: 2024

Comparative Functional Characterization of LuUGT74S1 from Linum usitatissimum L. and Its Closed Homologues from Fragaria vesca Subsp. vesca and Camellia sinensis

  • Authors: Sadiq S. Mareai, Thomas Hoffmann, Wilfried G. Schwab

  • Journal: ACS Food Science and Technology

  • Year: 2024

Liu Yakun | Biochemistry | Best Innovation Award

Posted on by sciencefather

Dr. Liu Yakun | Biochemistry | Best Innovation Award

The Fourth Hospital of Hebei Med, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Dr. Liu YaKun earned a Doctor of Medicine degree from the prestigious Hebei Medical University. From the beginning of her academic journey, she displayed a deep commitment to women’s health and a strong passion for advancing clinical knowledge in gynecology. Her formative years were shaped by rigorous medical education, clinical rotations, and early exposure to research in gynecologic oncology.

💼 Professional Endeavors

Currently serving as the Associate Chief Physician at the Department of Gynecology, Fourth Hospital of Hebei Medical University, Dr. Liu also holds the significant position of Teaching Director. In this dual role, she combines her medical expertise with academic leadership, mentoring young doctors and medical students. Her clinical work is particularly focused on the diagnosis and surgical treatment of gynecologic tumors, and she is widely recognized for her meticulous approach and dedication to patient care.

🔬 Contributions and Research Focus

Dr. Liu’s primary research area lies in gynecologic tumors, especially ovarian malignancies. In a groundbreaking study, she and her team became the first in the world to identify a rare germline BMP15 mutation as a causative factor in hereditary ovarian immature teratoma (OIT). Through a combination of cell line experiments and animal models, the pathogenicity of this mutation was verified, significantly advancing the understanding of the etiology of OIT. This work not only provided a crucial biomarker for genetic screening but also paved the way for future studies on ovarian malignant germ cell tumors.

🌍 Impact and Influence

Dr. Liu’s discovery has had a global impact, offering new insights into rare gynecologic cancers and influencing genetic screening protocols worldwide. Her pioneering research has opened new avenues in oncology, particularly in the identification and treatment of hereditary tumors in women, thus contributing significantly to precision medicine in gynecology.

📚 Academic Citations and Recognition

As a first author, Dr. Liu has published numerous papers in SCI-indexed and core medical journals, contributing high-impact literature to the field. She has led multiple research projects and was honored with the First Prize of the Hebei Medical Science and Technology Award, underscoring her scientific excellence and clinical relevance.

🧪 Technical Skills

Dr. Liu is proficient in a wide range of clinical and laboratory techniques, including tumor marker analysis, surgical oncology procedures, molecular biology experiments, and animal model development. Her work seamlessly integrates clinical practice with laboratory research, enabling her to translate bench-side findings into bedside applications.

👩‍🏫 Teaching Experience

As the Teaching Director of her department, Dr. Liu is deeply involved in medical education and mentoring. She designs and delivers advanced training modules for residents and interns, oversees their clinical rotations, and encourages them to participate in research. Her teaching style is both inspiring and practical, often merging clinical scenarios with research discussions to foster comprehensive learning.

🌟 Legacy and Future Contributions

Dr. Liu YaKun’s legacy is being built on a foundation of clinical innovation, academic excellence, and compassionate care. She aims to further explore genetic mutations in gynecologic oncology, contribute to personalized medicine, and mentor the next generation of gynecologists. Her future work will likely continue to bridge the gap between clinical practice and genetic research, reinforcing her standing as a trailblazer in women’s health.

📖Notable Publications

New insights into the ferroptosis and immune infiltration in endometriosis: a bioinformatics-based analysis

Authors: Lusha Liu, Feifei Han, Naiyi Du, Yakun Liu, Aihong Duan, Shan Kang, Bin Li
Journal: Frontiers in Immunology
Year: 2025

Incorporating genotype information in a precise prediction model for platinum sensitivity in epithelial ovarian cancer

Authors: Nai-Yi Du, Yan Li, Hui Zheng, Ya-Kun Liu, Lu-Sha Liu, Jianbang Xie, Shan Kang
Journal: Frontiers in Oncology
Year: 2025

Stratifin (SFN) Regulates Cervical Cancer Cell Proliferation, Apoptosis, and Cytoskeletal Remodeling and Metastasis Progression Through LIMK2/Cofilin Signaling

Authors: Naiyi Du, Daojuan Li, Wei Zhao, Yakun Liu
Journal: Molecular Biotechnology
Year: 2024

The Diagnostic Significance of Combined Screening and Human Papillomavirus 16 and 18 Cycle Threshold Values for CIN2+ Cervical Lesions

Authors: Xue Bai, Ya-Kun Liu, Ya-Jing Jia, Dao-Juan Li, Nai-Yi Du
Journal: International Journal of Women’s Health
Year: 2024

Causal effects of genetically determined circulating metabolites on endometriosis: A Mendelian randomization study

Authors: Lusha Liu, Junping Yin, Yakun Liu, Bin Li, Shan Kang, Naiyi Du
Journal: Medicine
Year: 2024

LIMK1 promotes the development of cervical cancer by up-regulating the ROS/Src-FAK/cofilin signaling pathway

Authors: Yajing Jia, Yongping Li, Naiyi Du, Wei Zhao, Yakun Liu
Journal: Aging
Year: 2024

Fei Yao | Biochemistry | Best Researcher Award

Posted on by sciencefather

Prof. Fei Yao | Biochemistry | Best Researcher Award

The First Affiliated Hospital of Guangxi Medical University, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Prof. Fei Yao’s journey in academia began with a strong foundation in biochemistry and medical sciences. With a keen interest in cancer biology, Prof. Yao pursued higher education in oncology, eventually earning a medical degree and further advancing into postdoctoral research. This rigorous academic training laid the groundwork for future contributions to cancer research.

🏥 Professional Endeavors

Currently serving as a Professor of Oncology at The First Affiliated Hospital of Guangxi Medical University, China, and The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Prof. Yao has seamlessly integrated clinical expertise with research innovations. As a medical doctor and postdoctoral fellow, Prof. Yao also mentors master’s students, shaping the next generation of researchers in oncology and biochemistry.

🔬 Contributions and Research Focus

Prof. Yao’s research primarily focuses on tumor microenvironment mechanisms and the development of clinical drugs for cancer treatment. By leading multiple prestigious research projects funded by:

  • 🏅 National Natural Science Foundation of China
  • 🏅 China Postdoctoral Science Foundation
  • 🏅 Guangxi Natural Science Foundation

Prof. Yao has significantly contributed to understanding how cancer cells interact with their surroundings, paving the way for novel therapeutic strategies.

📚 Impact and Influence

Prof. Yao has published multiple SCI-indexed research papers, adding valuable insights to the field of oncology and biochemistry. These studies have not only been widely cited but have also influenced clinical applications and drug development in cancer research.

📖 Academic Citations & Recognition

With a robust research portfolio, Prof. Yao’s work has been cited extensively in international journals, reinforcing its scientific impact. These contributions continue to shape the landscape of cancer treatment and personalized medicine.

🛠️ Technical Skills & Expertise

Prof. Yao possesses expertise in various advanced biochemical and clinical research techniques, including:
✔️ Tumor Microenvironment Analysis
✔️ Cell Culture & Molecular Biology Techniques
✔️ Targeted Drug Development for Cancer
✔️ Clinical Trials & Experimental Therapies
✔️ Biostatistical Analysis & Research Methodologies

🎓 Teaching and Mentorship

As a Master’s Supervisor, Prof. Yao plays a crucial role in mentoring graduate students, guiding them in research methodologies, experimental designs, and thesis development. Many students have benefited from this mentorship, progressing in their careers as medical researchers and clinicians.

🌎 Legacy and Future Contributions

With a deep commitment to advancing cancer research, Prof. Yao aims to:
🔹 Continue exploring innovative treatments targeting the tumor microenvironment.
🔹 Bridge the gap between traditional Chinese medicine and modern oncology.
🔹 Develop next-generation clinical drugs to improve patient outcomes.
🔹 Inspire young researchers to contribute meaningfully to biochemistry and oncology.

🏆 Conclusion

Prof. Fei Yao’s dedication to biochemistry and cancer research has established a remarkable legacy in oncology, drug development, and clinical applications. As an esteemed professor, researcher, and mentor, Prof. Yao’s contributions will continue to impact the field for years to come.

📖Notable Publications

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients

Authors: L. Zhong, L. Gan, B. Wang, W. Shi, Y. Zhao

Journal: Cell

Year: 2025

Yaoyao Li | Bioinformatics | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Yaoyao Li | Bioinformatics | Best Researcher Award

Xidian University, China

👨‍🎓Profiles

Early Academic Pursuits 🎓

Yaoyao Li, Ph.D., began her academic journey at Xidian University, where she earned her Ph.D. in Computer Science and Technology in June 2020. During her doctoral studies, she focused on computational techniques for analyzing biomolecular data, particularly DNA genome sequences. Her early academic pursuits were marked by a strong foundation in machine learning algorithms, probability theory, and statistical methods applied to bioinformatics. Her work aimed to detect and identify variant sites or fragments within DNA, uncovering patterns with potential biological functions. This laid the groundwork for her future contributions to computational bioinformatics and genomic research.

Professional Endeavors 💼

Following the completion of her Ph.D., Dr. Li worked at Alibaba Group from July 2020 to June 2022. Here, she was responsible for researching user growth algorithms for business-to-business (B2B) applications. Her work contributed to key innovations in user engagement, earning her the Core Innovation Technology Award. This professional experience allowed her to bridge the gap between theoretical research and real-world applications. After her tenure at Alibaba, she continued her academic journey by completing postdoctoral research at Xidian University in June 2024, solidifying her expertise in computational techniques and bioinformatics.

Contributions and Research Focus 🔬

Dr. Li's research is at the intersection of machine learning, computer vision, computational bioinformatics, and cancer genome data mining. Her primary focus is on analyzing biomolecular data to reveal biological insights hidden within DNA sequences. She employs comprehensive machine learning algorithms and probabilistic methods to detect variant sites or identify DNA fragments, helping to uncover biological patterns that may play a role in diseases such as cancer. Dr. Li is particularly passionate about integrating statistical tests with advanced machine learning models to improve accuracy in genome sequence prediction.

Impact and Influence 🌍

Dr. Li's work has had a significant impact on the field of bioinformatics and genomic research. By developing algorithms that can detect variant sites in the DNA genome, her contributions are pivotal in understanding complex genetic diseases, especially cancer. Her research also aids in the development of precision medicine, where targeted therapies can be crafted based on an individual’s genetic makeup. The practical implications of her research extend to biotechnology companies, healthcare providers, and academic institutions focused on genomics.

In addition to her research, Dr. Li's efforts to contribute to the academic community are reflected in her involvement with prestigious journals such as "Digital Signal Processing", "IEEE/ACM Transactions on Computational Biology and Bioinformatics", and "Biomedical Optics Express". Her papers have been widely cited, making her a respected voice in the fields of computational biology and bioinformatics.

Academic Cites and Recognition 📚

Dr. Li’s research has been widely recognized within the academic community. Her contributions to bioinformatics and computational techniques have been cited in major international journals, reinforcing her reputation as a leader in the field. Her publications in well-respected journals, such as IEEE/ACM Transactions on Computational Biology and Biomedical Optics Express, have garnered attention for their innovative approaches to cancer genome data mining and DNA sequence analysis. These citations are a testament to her academic influence and the relevance of her work to both fundamental and applied science.

Technical Skills 🛠️

Dr. Li’s expertise spans several domains of computational science, particularly in the application of machine learning algorithms, probability theory, and statistical methods. She is highly skilled in using these techniques to detect variant sites, identify fragments in DNA genomes, and mine cancer genomic data. Her proficiency with computer vision methods further strengthens her research capabilities, allowing her to work with complex biological data sets. Dr. Li is also adept at leveraging sequence prediction models to enhance the accuracy of her findings.

Teaching Experience 👩‍🏫

Dr. Li has shared her knowledge and expertise through her involvement in teaching and mentoring students. While her focus has been on cutting-edge research, she has also contributed to the academic growth of her students, guiding them through complex topics in bioinformatics, machine learning, and computational biology. Her ability to simplify intricate scientific concepts has made her a respected mentor, and she continues to inspire the next generation of researchers in her field.

Legacy and Future Contributions 🔮

Dr. Li's legacy is one of blending advanced computational techniques with real-world biomedical applications. Her work has already made a substantial impact in the field of genomic research, particularly in cancer genomics, and has the potential to revolutionize how diseases are diagnosed and treated. Looking to the future, she aims to further expand the applications of machine learning in genomic research and bioinformatics, exploring new methods for early detection of genetic diseases. She is also committed to advancing the precision medicine field, ensuring that personalized healthcare strategies are built on robust genomic data analysis.

Final Thoughts 🌟

Dr. Yaoyao Li is a trailblazer in computational bioinformatics, and her research has already had a profound impact on the scientific community. With her expertise in machine learning, bioinformatics, and cancer genomics, she is poised to continue making significant contributions that will not only advance academic knowledge but also improve health outcomes through precision medicine. Her journey is a testament to the power of combining computational technology with biological science to solve some of the most pressing challenges in modern healthcare.

📖Notable Publications

CNV_MCD: Detection of copy number variations based on minimum covariance determinant using next-generation sequencing data

Authors: Li, Y., Yang, F., Xie, K.
Journal: Digital Signal Processing: A Review Journal
Year: 2024

Intelligent scoring system based on dynamic optical breast imaging for early detection of breast cancer

Authors: Li, Y., Zhang, Y., Yu, Q., He, C., Yuan, X.
Journal: Biomedical Optics Express
Year: 2024

CONDEL: Detecting Copy Number Variation and Genotyping Deletion Zygosity from Single Tumor Samples Using Sequence Data

Authors: Yuan, X., Bai, J., Zhang, J., Li, Y., Gao, M.
Journal: IEEE/ACM Transactions on Computational Biology and Bioinformatics
Year: 2020

DpGMM: A Dirichlet Process Gaussian Mixture Model for Copy Number Variation Detection in Low-Coverage Whole-Genome Sequencing Data

Authors: Li, Y., Zhang, J., Yuan, X., Li, J.
Journal: IEEE Access
Year: 2020

BagGMM: Calling copy number variation by bagging multiple Gaussian mixture models from tumor and matched normal next-generation sequencing data

Authors: Li, Y., Zhang, J., Yuan, X.
Journal: Digital Signal Processing: A Review Journal
Year: 2019

SM-RCNV: A statistical method to detect recurrent copy number variations in sequenced samples

Authors: Li, Y., Yuan, X., Zhang, J., Bai, J., Jiang, S.
Journal: Genes and Genomics
Year: 2019